Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Freeman

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|January 27, 2012
Co-amoxiclav induces proliferation and cytotoxin production of Clostridium difficile ribotype 027 in a human gut modelCaroline H Chilton, Jane Freeman, Grace S Crowther, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2013
Evaluation of antimicrobial activity of ceftaroline against Clostridium difficile and propensity to induce C. difficile infection in an in vitro human gut modelSimon D Baines, Caroline H Chilton, Grace S Crowther, et al.
The Journal of Antimicrobial Chemotherapy|September 12, 2012
Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infectionGrace S Crowther, Simon D Baines, Sharie L Todhunter, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 30, 2025
Antimicrobial susceptibility testing of Clostridioides difficile: a dual-site study of three different media and three therapeutic antimicrobialsJane Freeman, Ingrid M J G Sanders, Céline Harmanus, et al.
Plos One|February 12, 2014
Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of Clostridium difficile and human microbiotaGrace S Crowther, Caroline H Chilton, Sharie L Todhunter, et al.
The Journal of Antimicrobial Chemotherapy|May 3, 2014
Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut modelGrace S Crowther, Caroline H Chilton, Sharie L Todhunter, et al.
Nature Reviews. Microbiology|October 2, 2025
Clostridioides difficile pathogenesis and controlCaroline H Chilton, Virginie Viprey, Charmaine Normington, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2013
Mixed infection by Clostridium difficile in an in vitro model of the human gutSimon D Baines, Grace S Crowther, Sharie L Todhunter, et al.
Infection Control and Hospital Epidemiology|July 11, 2007
Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strainsWarren N Fawley, Sarah Underwood, Jane Freeman, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2008
Emergence of reduced susceptibility to metronidazole in Clostridium difficileSimon D Baines, Rachael O'Connor, Jane Freeman, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|January 27, 2012
Co-amoxiclav induces proliferation and cytotoxin production of Clostridium difficile ribotype 027 in a human gut modelCaroline H Chilton, Jane Freeman, Grace S Crowther, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2013
Evaluation of antimicrobial activity of ceftaroline against Clostridium difficile and propensity to induce C. difficile infection in an in vitro human gut modelSimon D Baines, Caroline H Chilton, Grace S Crowther, et al.
The Journal of Antimicrobial Chemotherapy|September 12, 2012
Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infectionGrace S Crowther, Simon D Baines, Sharie L Todhunter, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 30, 2025
Antimicrobial susceptibility testing of Clostridioides difficile: a dual-site study of three different media and three therapeutic antimicrobialsJane Freeman, Ingrid M J G Sanders, Céline Harmanus, et al.
Plos One|February 12, 2014
Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of Clostridium difficile and human microbiotaGrace S Crowther, Caroline H Chilton, Sharie L Todhunter, et al.
The Journal of Antimicrobial Chemotherapy|May 3, 2014
Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut modelGrace S Crowther, Caroline H Chilton, Sharie L Todhunter, et al.
Nature Reviews. Microbiology|October 2, 2025
Clostridioides difficile pathogenesis and controlCaroline H Chilton, Virginie Viprey, Charmaine Normington, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2013
Mixed infection by Clostridium difficile in an in vitro model of the human gutSimon D Baines, Grace S Crowther, Sharie L Todhunter, et al.
Infection Control and Hospital Epidemiology|July 11, 2007
Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strainsWarren N Fawley, Sarah Underwood, Jane Freeman, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2008
Emergence of reduced susceptibility to metronidazole in Clostridium difficileSimon D Baines, Rachael O'Connor, Jane Freeman, et al.
Pageof 6